课题基金 / 基金详情

Structural mechanism of Roquin-RNA interactions linked to autoimmunity

Structural mechanism of Roquin-RNA interactions linked to autoimmunity
Roquin-RNA相互作用与自身免疫相关的结构机制
批准号:
248331224
负责人:
Dr. Andreas Schlundt
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2014
资助国家:
德国
项目状态:
已结题
起止时间:
2013-12-31 至 2016-12-31

项目摘要

项目成果

Dr. Andreas Schlundt的其他基金

相似基金

相关文献

中文摘要
翻译
自身免疫性疾病仍然对现代文明构成重大挑战。虽然在过去的世纪中,由入侵病原体引起的许多灾难性感染已经被遏制,但越来越多的患者患有自身免疫性疾病和/或对过敏原的超敏反应。了解自身免疫反应的分子机制是成功和特异性治疗的关键方法。免疫应答的重要作用归因于T细胞共刺激受体。本研究的目的是揭示RNA结合蛋白Roquin抑制诱导型T细胞共刺激表面受体(ICOS)的分子细节。已知ICOS的表达受迄今未知机制的转录后调控。ICOS mRNA由Roquin调查,调节异常是系统性自身免疫的主要原因,具有已知的红斑狼疮症状,主要通过结缔组织破坏显示。除了ICOS,拟议的研究将包括其他描述良好的Roquin mRNA靶点,如Ox 40和TNF-α,以研究在结构水平上抑制相应的细胞表面受体。Roquin的分子功能和三维结构在很大程度上是未知的。因此,本研究旨在研究Roquin的结构细节,其与ICOS和其他mRNA的结合,并最终招募辅助因子。Roquin包含RING和锌指结构域以及RNA结合所需的称为ROQ的新结构域。拟议的研究旨在揭示ROQ结构域与RNA结合的结构细节,并阐明mRNA水平调节免疫反应的分子机制。该研究将侧重于实验结构生物学,使用核磁共振(NMR)光谱学和X射线晶体学,生物化学和生物物理研究来表征分子相互作用与功能分析(合作)。研究Roquin与ICOS和其他mRNA复合的结构有望揭示自身免疫的分子机制,这将对mRNA水平的免疫调节产生更广泛的影响。
英文摘要
Autoimmune diseases still pose a major challenge to modern civilizations. While many disastrous infections, caused by invading pathogens, have been contained during the past century, a growing number of patients suffer from autoimmune diseases and/or hypersensitivity against allergens. Understanding molecular mechanisms of autoimmune reactions is a key approach towards successful and specific treatment. An important role for the immune response is ascribed to T-cell co-stimulatory receptors. This study, exemplarily, aims at revealing the molecular details of the repression of the inducible T cell co-stimulatory surface receptor (ICOS) by the RNA binding protein Roquin. The expression of ICOS is known to be regulated post-transcriptionally by so far unknown mechanisms. ICOS mRNA is surveyed by Roquin and dysregulation is a major cause for systemic autoimmunity with symptoms known from Lupus Erythematosus, mainly displayed through the destruction of connective tissue. Besides ICOS, the proposed study will include additional well-described Roquin mRNA targets like Ox40 and TNF-alpha to also investigate the suppression of respective cell surface receptors on the structural level.Molecular functions and the three-dimensional structure of Roquin are largely unknown. This study therefore aims at investigating structural details of Roquin, its binding to the ICOS- and other mRNAs, and eventually the recruitment of co-factors. Roquin comprises RING and zinc finger domains and a novel domain, termed ROQ, which is required for RNA binding. The proposed research aims at revealing the structural details of RNA binding by the ROQ domain and elucidating molecular mechanisms of the regulation of immune responses at the level of mRNA. The research will focus on experimental structural biology, using nuclear magnetic resonance (NMR) spectroscopy and X-ray crystallography, biochemical and biophysical studies to characterize the molecular interactions combined with functional analysis (in collaboration). Examining Roquin's structure in complex with ICOS- and other mRNAs is expected to reveal a molecular mechanism of autoimmunity that will have more general implications for the regulation of immunity at the level of mRNA.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1038/nsmb.2855
发表时间: 2014-08-01
期刊: NATURE STRUCTURAL & MOLECULAR BIOLOGY
影响因子: 16.8
作者: [Schlundt, Andreas, Heinz, Gitta A., Sattler, Michael]
通讯作者: Sattler, Michael
RNA recognition by Roquin in posttranscriptional gene regulation
Roquin 在转录后基因调控中的 RNA 识别
DOI: 10.1002/wrna.1333
发表时间: 2016
期刊: Wiley Interdisciplinary Reviews: RNA
影响因子: --
作者: [Schlundt A, Niessing D, Heissmeyer V, Sattler M]
通讯作者: Sattler M
Cis- and trans-acting determinants of mRNA stability, structure and fate (as a continuation)
  • 批准号:
    404540462
  • 项目类别:
    Independent Junior Research Groups
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Dr. Andreas Schlundt
  • 依托单位:
国内基金
海外基金
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
  • 批准号:
    82371616
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    姚晨成
  • 依托单位:
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
  • 批准号:
    82371634
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    赵福军
  • 依托单位:
生物钟核受体Rev-erbα在缺血性卒中神经元能量代谢中的改善作用及机制研究
  • 批准号:
    82371332
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    胡琴
  • 依托单位:
超声驱动压电效应激活门控离子通道促眼眶膜内成骨的作用及机制研究
  • 批准号:
    82371103
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    阮静
  • 依托单位: